NCS7
NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
07/29/2026
Back to search
Official data from USPTO
AMP
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILEDType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Case type
Application and registration
Recorded events
26
Latest update
08/17/2026
Trademark type
Combined
Nice classes
40, 42
Filing date
01/26/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2026
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
711
Official register
Principal Register
First use anywhere
01/16/2024
First use in commerce
01/16/2024
Drawing code
3
Owner type
16
Owner location
LAKE FOREST, IL, US
Examiner
BARREDA, AMBER KYLEE
Current location
Historical data usage
Mark description
The mark consists of the word "AMP" in capital letters above a design suggestive of a chromosome with an electrical bolt forming the junction of the two halves of the chromosome.
Holders and representatives
Holders
JAGUAR GENE THERAPY, LLC
Advanced Medicine Partners, LLC
Representatives
J. Dickson Phillips III ROBINSON BRADSHAW & HINSON, P.A.
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Biomanufacturing for othersmanufacturing of pharmaceuticals using biological organism in the manufacturing process; custom manufacture for others of products relating to biotechnologyrecombinant proteins for use in the biotechnology industries; custom manufacture for others of cell therapy products; custom manufacture for others of gene therapy products; custom manufacture of pharmaceuticals in accordance with specific standards GMP regulations
Class 42
Contract development and manufacturing organization (CDMO) servicespharmaceutical drug development services; consulting and advisory services in the field of analytical development and quality control testing of pharmaceuticalgene therapycell therapy products; consulting and advisory services in the field of manufacturing process development for pharmaceuticalgene therapy and cell therapy products; consulting in the field of chemistry manufacturing and controls (CMC) activities; testing of pharmaceuticalgene therapycell therapy products and materials; quality control testing of pharmaceutical products and materialsbiopharmaceutical products and materials in accordance with specifications or requirements of regulatory standards applicable in target countries; testing and validation services of biopharmaceutical products to assure compliance with global regulatory requirementsspecificationsindustry standards for pharmaceuticalcell therapy and gene therapy methods of development; technical consulting for regulatory compliance in the field of chemistry manufacturing and controls (CMC)
Publications
History of USPTO decisions and trademark events.
26 publications found
C7..
CANCELLED SECTION 7-TOTAL
07/29/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/29/2026
C7RF
REQUEST FOR SECT 7 TOTAL SURRENDER FILED
07/15/2026
ES7S
TEAS SECTION 7 SURRENDER RECEIVED
07/15/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/27/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/17/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/19/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/05/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
11/15/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
11/15/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/20/2024
GNRT
NON-FINAL ACTION E-MAILED
08/20/2024
CNRT
NON-FINAL ACTION WRITTEN
08/20/2024
DOCK
ASSIGNED TO EXAMINER
08/12/2024
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2024
NWAP
NEW APPLICATION ENTERED
01/30/2024
Continuous trademark protection
Get notified about every new filing that threatens AMP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.